| CMXHF Stock | | | USD 171.54 0.81 0.47% |
Insider
MS BA is Ex Officer of CSL Limited
| Age | 53 |
| Phone | 61 3 9389 1911 |
| Web | https://www.csl.com.au |
CSL Management Efficiency
The company has return on total asset
(ROA) of
0.0798 % which means that it generated a profit of $0.0798 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.1964 %, meaning that it generated $0.1964 on every $100 dollars invested by stockholders. CSL's management efficiency ratios could be used to measure how well CSL manages its routine affairs as well as how well it operates its assets and liabilities.
CSL Limited has accumulated 3.86
B in total debt with debt to equity ratio
(D/E) of 0.66, which is about average as compared to similar companies. CSL Limited has a current ratio of 2.27, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist CSL until it has trouble settling it off, either with new capital or with free cash flow. So, CSL's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CSL Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CSL to invest in growth at high rates of return. When we think about CSL's use of debt, we should always consider it together with cash and equity.
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. Csl operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 30000 people. CSL Limited [CMXHF] is a
Pink Sheet which is traded between brokers over the counter.
Management Performance
CSL Limited Leadership Team
Elected by the shareholders, the CSL's board of directors comprises two types of representatives: CSL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CSL. The board's role is to monitor CSL's management team and ensure that shareholders' interests are well served. CSL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CSL's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Paul McKenzie, Chief Officer | |
| BCom BComm, Chief Officer | |
| Wilfried Freudenberg, Department Production | |
| Christina Hickie, Sr Communications | |
| BS BS, Exec Counsel | |
| MS BA, Ex Officer | |
| Karen Etchberger, Executive VP of Quality and Bus. Services | |
| Paul BA, CEO MD | |
| Jemimah Brennan, Head Pacific | |
| Mark Dehring, Director of Investor Relations, IR Contact Officer | |
CSL Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is CSL a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in CSL Pink Sheet
CSL financial ratios help investors to determine whether CSL Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSL with respect to the benefits of owning CSL security.